BioCentury
ARTICLE | Company News

Fera Pharmaceuticals LLC deal

August 2, 2010 7:00 AM UTC

Fera acquired an itraconazole topical suspension to treat fungal otitis externa from an undisclosed company. The compound has Orphan Drug designation in the U.S. for the indication. Financial terms an...